Daniel L. Reuvers
2017
Compensation breakdown
Non-Equity Incentive Plan | $375,000 |
---|---|
Option Awards | $112,514 |
Salary | $407,258 |
Stock Awards | $262,560 |
Other | $117,726 |
Total | $1,275,058 |
Reuvers received $407.3K in salary, accounting for 32% of the total pay in 2017.
Reuvers also received $375K in non-equity incentive plan, $112.5K in option awards, $262.6K in stock awards and $117.7K in other compensation.
Rankings
In 2017, Daniel L. Reuvers' compensation ranked 7,810th out of 14,666 executives tracked by ExecPay. In other words, Reuvers earned more than 46.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,810 | 47th |
Manufacturing | 2,929 | 49th |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 380 | 56th |
Surgical, Medical, And Dental Instruments And Supplies | 200 | 62nd |
Surgical and Medical Instruments and Apparatus | 120 | 64th |
Reuvers' colleagues
We found four more compensation records of executives who worked with Daniel L. Reuvers at Integra LifeSciences Holdings in 2017.
2017
Peter Arduini
Integra LifeSciences Holdings
Chief Executive Officer
2017
Glenn Coleman
Integra LifeSciences Holdings
Chief Financial Officer
2017
Robert Davis
Integra LifeSciences Holdings
Corporate Vice President, President, Orthopedics and Tissue Technologies
2017
Richard Gorelick
Integra LifeSciences Holdings